Clinical trial
A Phase II Prospective Trial of Prophylactic Donor Lymphocyte Infusions for the Prevention of Relapse Post HSCT in Patients With High Risk Myeloid Malignancy
NCT02856464 is registered in ClinicalTrials.gov with King's College Hospital NHS Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Prospective Trial of Prophylactic Donor Lymphocyte Infusions for the Prevention of Relapse Post HSCT in Patients With High Risk Myeloid Malignancy
- Lead sponsor
- King's College Hospital NHS Trust
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- December 21, 2016
- Completion date
- September 30, 2020
- Enrollment
- 124 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.